{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:15:04Z","timestamp":1773324904794,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.pupt.2015.08.005","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T18:15:17Z","timestamp":1439921717000},"page":"46-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"34","author":[{"given":"Liang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Jie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.pupt.2015.08.005_bib1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2165\/10898570-000000000-00000","article-title":"Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches","volume":"70","author":"Bosma","year":"2010","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.pupt.2015.08.005_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/jp.2011.125","article-title":"Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study","volume":"33","author":"Ramanathan","year":"2013","journal-title":"J.\u00a0Perinatol."},{"issue":"6","key":"10.1016\/j.pupt.2015.08.005_bib3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1542\/peds.2010-3212","article-title":"Neonatal mortality from respiratory distress syndrome: lessons for low-resource countries","volume":"127","author":"Kamath","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.pupt.2015.08.005_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0031-1295648","article-title":"A\u00a0randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome","volume":"29","author":"Dizdar","year":"2012","journal-title":"Am. J. Perinatol."},{"issue":"1","key":"10.1016\/j.pupt.2015.08.005_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/pr.2014.54","article-title":"Administration of antenatal glucocorticoids and postnatal surfactant ameliorates respiratory distress syndrome-associated neonatal lethality in Erk3(-\/-) mouse pups","volume":"76","author":"Cuevas Guaman","year":"2014","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.pupt.2015.08.005_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000151749","article-title":"Choosing a right surfactant for respiratory distress syndrome treatment","volume":"95","author":"Ramanathan","year":"2009","journal-title":"Neonatology"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.pupt.2015.08.005_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/14767058.2010.509912","article-title":"Old and new uses of surfactant","volume":"23","author":"Gizzi","year":"2010","journal-title":"J.\u00a0Matern. Fetal Neonatal Med."},{"issue":"4","key":"10.1016\/j.pupt.2015.08.005_bib8","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.2004-2231","article-title":"A\u00a0multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome","volume":"115","author":"Sinha","year":"2005","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.pupt.2015.08.005_bib9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1542\/peds.2004-2783","article-title":"Infasurf survanta clinical trial G. Comparison of Infasurf (calfactant) and Survanta (beractant) in the prevention and treatment of respiratory distress syndrome","volume":"116","author":"Bloom","year":"2005","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.pupt.2015.08.005_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2165\/00019053-200826090-00006","article-title":"Use of indirect and mixed treatment comparisons for technology assessment","volume":"26","author":"Sutton","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"10.1016\/j.pupt.2015.08.005_bib11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S1470-2045(13)70388-7","article-title":"Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis","volume":"14","author":"Liao","year":"2013","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.pupt.2015.08.005_bib12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.pupt.2015.08.005_bib13","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.pupt.2015.08.005_bib14","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1541-0420.2012.01761.x","article-title":"A\u00a0method of moments estimator for random effect multivariate meta-analysis","volume":"68","author":"Chen","year":"2012","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.pupt.2015.08.005_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/gepi.20048","article-title":"Heterogeneity testing in meta-analysis of genome searches","volume":"28","author":"Zintzaras","year":"2005","journal-title":"Genet. Epidemiol."},{"issue":"10","key":"10.1016\/j.pupt.2015.08.005_bib16","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"issue":"7387","key":"10.1016\/j.pupt.2015.08.005_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","article-title":"Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses","volume":"326","author":"Song","year":"2003","journal-title":"BMJ"},{"issue":"138","key":"10.1016\/j.pupt.2015.08.005_bib18","article-title":"Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons","volume":"12","author":"Song","year":"2012","journal-title":"BMC Med. Res. Methodol."},{"issue":"7109","key":"10.1016\/j.pupt.2015.08.005_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.pupt.2015.08.005_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Res. Synthesis Methods"},{"issue":"7","key":"10.1016\/j.pupt.2015.08.005_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s12098-010-0097-y","article-title":"Complications among premature neonates treated with beractant and poractant alfa","volume":"77","author":"Gharehbaghi","year":"2010","journal-title":"Indian J. Pediatr."},{"issue":"4","key":"10.1016\/j.pupt.2015.08.005_bib22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jpeds.2013.04.053","article-title":"Comparative effectiveness of surfactant preparations in premature infants","volume":"163","author":"Trembath","year":"2013","journal-title":"J.\u00a0Pediatr."},{"issue":"1","key":"10.1016\/j.pupt.2015.08.005_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.rmed.2006.03.033","article-title":"Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants","volume":"101","author":"Proquitte","year":"2007","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.pupt.2015.08.005_bib24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1651-2227.2000.tb00328.x","article-title":"Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?","volume":"89","author":"Kukkonen","year":"2000","journal-title":"Acta Paediatr."},{"issue":"5","key":"10.1016\/j.pupt.2015.08.005_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/(SICI)1099-0496(199905)27:5<312::AID-PPUL3>3.0.CO;2-N","article-title":"Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country","volume":"27","author":"da Costa","year":"1999","journal-title":"Pediatr. Pulmonol."},{"issue":"1","key":"10.1016\/j.pupt.2015.08.005_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1542\/peds.100.1.39","article-title":"A\u00a0multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome","volume":"100","author":"Hudak","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.pupt.2015.08.005_bib27","series-title":"A\u00a0multicenter randomized, masked comparison trial of natural versus synthetic surfactant for treatment of respiratory distress syndrome","author":"Hudak","year":"1996"},{"issue":"3","key":"10.1016\/j.pupt.2015.08.005_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2004-823779","article-title":"The North American study group. A randomized, multicenter masked comparison trial of Poractant Alfa (Curosurf) versus Beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants","volume":"21","author":"Ramanathan","year":"2004","journal-title":"Am. J. Perinatol."},{"issue":"1","key":"10.1016\/j.pupt.2015.08.005_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1542\/peds.100.1.31","article-title":"Comparison of Infasurf (Calf Lung Surfactant Extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome","volume":"100","author":"Bloom","year":"1997","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.pupt.2015.08.005_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/jp.2010.20","article-title":"Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome","volume":"30","author":"Fujii","year":"2010","journal-title":"J.\u00a0Perinatol."},{"issue":"2","key":"10.1016\/j.pupt.2015.08.005_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1442-200x.2002.01527.x","article-title":"Comparative randomized study: administration of natural and synthetic surfactant to premature newborns with respiratory distress syndrome","volume":"44","author":"Giannakopoulou","year":"2002","journal-title":"Pediatr. Int."},{"issue":"4","key":"10.1016\/j.pupt.2015.08.005_bib32","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1542\/peds.2004-2183","article-title":"A\u00a0multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants","volume":"115","author":"Moya","year":"2005","journal-title":"Pediatrics"},{"issue":"7\u20138","key":"10.1016\/j.pupt.2015.08.005_bib33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00431-002-1144-0","article-title":"Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome","volume":"162","author":"Baroutis","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.pupt.2015.08.005_bib34","series-title":"Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome","author":"Speer","year":"1995"},{"key":"10.1016\/j.pupt.2015.08.005_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1874306401206010044","article-title":"The role of surfactant in respiratory distress syndrome","volume":"6","author":"Ma","year":"2012","journal-title":"Open Respir. Med. J."},{"issue":"1","key":"10.1016\/j.pupt.2015.08.005_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1542\/peds.2013-3443","article-title":"Committee on F, Newborn, American Academy of P. Surfactant replacement therapy for preterm and term neonates with respiratory distress","volume":"133","author":"Polin","year":"2014","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.pupt.2015.08.005_bib37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/ppul.21460","article-title":"Bronchoalveolar lavage versus bolus administration of lucinactant, a synthetic surfactant in meconium aspiration in newborn lambs","volume":"46","author":"Rey-Santano","year":"2011","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.pupt.2015.08.005_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1465-9921-13-17","article-title":"Poractant alfa (Curosurf(R)) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in\u00a0vivo","volume":"13","author":"Willems","year":"2012","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.pupt.2015.08.005_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14767050410001668266","article-title":"Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome","volume":"15","author":"Hammoud","year":"2004","journal-title":"J.\u00a0Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.pupt.2015.08.005_bib40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cis.2014.07.012","article-title":"Evaluation of therapeutic pulmonary surfactants by thin liquid film methods","volume":"222","author":"Todorov","year":"2015","journal-title":"Adv. Colloid Interface Sci."},{"issue":"12","key":"10.1016\/j.pupt.2015.08.005_bib41","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/mabi.201000033","article-title":"Charge and size dependence of liposome diffusion in semidilute biopolymer solutions","volume":"10","author":"Rusu","year":"2010","journal-title":"Macromol. Biosci."},{"issue":"4","key":"10.1016\/j.pupt.2015.08.005_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/092986708783497364","article-title":"Synthetic pulmonary surfactant preparations: new developments and future trends","volume":"15","author":"Mingarro","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.pupt.2015.08.005_bib43","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jdiacomp.2013.04.011","article-title":"New options for the treatment of obesity and type 2 diabetes mellitus (narrative review)","volume":"27","author":"Henry","year":"2013","journal-title":"J.\u00a0Diabetes Complicat."},{"issue":"6","key":"10.1016\/j.pupt.2015.08.005_bib44","doi-asserted-by":"crossref","first-page":"e1361","DOI":"10.1542\/peds.2006-0149","article-title":"One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials","volume":"119","author":"Moya","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.pupt.2015.08.005_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/213239","article-title":"A\u00a0network meta-analysis on randomized trials focusing on the preventive effect of statins on contrast-induced nephropathy","volume":"2014","author":"Peruzzi","year":"2014","journal-title":"Biomed. Res. Int."}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553915000905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553915000905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T05:26:45Z","timestamp":1537421205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553915000905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":45,"alternative-id":["S1094553915000905"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2015.08.005","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2015.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}